University of Groningenfounded in 1614  -  top 100 university
Close
Research Research database

Diabetes Care, 0149-5992

Journal

1 - 50 out of 145Page size: 50
  1. 2020
  2. DAPA-HF Investigators and Committees (2020). Dapagliflozin and the Incidence of Type 2 Diabetes in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis From DAPA-HF. Diabetes Care. https://doi.org/10.2337/dc20-1675
  3. Muskiet, M. H. A., Tonneijck, L., Smits, M. M., Kramer, M. H. H., Ouwens, D. M., Hartmann, B., Holst, J. J., Touw, D. J., Danser, A. H. J., Joles, J. A., & van Raalte, D. H. (2020). Effects of DPP-4 Inhibitor Linagliptin Versus Sulfonylurea Glimepiride as Add-on to Metformin on Renal Physiology in Overweight Patients With Type 2 Diabetes (RENALIS): A Randomized, Double-Blind Trial. Diabetes Care, 43(10), 2889-2893. https://doi.org/10.2337/dc20-0902
  4. Szili-Torok, T., Bakker, S. J. L., & Tietge, U. J. F. (2020). Statin Use Is Prospectively Associated With New-Onset Diabetes After Transplantation in Renal Transplant Recipients. Diabetes Care, 43(8), 1945-1947. https://doi.org/10.2337/dc19-1212
  5. 2019
  6. Yeung, S. M. H., Binnenmars, S. H., Gant, C. M., Navis, G., Gansevoort, R. T., Bakker, S. J. L., de Borst, M., & Laverman, G. D. (2019). Fibroblast Growth Factor 23 and Mortality in Patients With Type 2 Diabetes and Normal or Mildly Impaired Kidney Function. Diabetes Care, 42(11), 2151-2153. https://doi.org/10.2337/dc19-0528
  7. Gomes-Neto, A. W., Oste, M. C. J., Sotomayor, C. G., Van der Berg, E., Geleijnse, J. M., Gans, R. O. B., Bakker, S. J. L., & Navis, G. J. (2019). Fruit and Vegetable Intake and Risk of Posttransplantation Diabetes in Renal Transplant Recipients. Diabetes Care, 42(9), 1645-1652. https://doi.org/10.2337/dc19-0224
  8. ASIAN-HF Investigators, Tromp, J., Lim, S. L., Tay, W. T., Teng, T-H. K., Chandramouli, C., Ouwerkerk, W., Wander, G. S., Sawhney, J. P. S., Yap, J., MacDonald, M. R., Ling, L. H., Sattar, N., McMurray, J. J. V., Richards, A. M., Anand, I., & Lam, C. S. P. (2019). Microvascular Disease in Patients With Diabetes With Heart Failure and Reduced Ejection Versus Preserved Ejection Fraction. Diabetes Care, 42(9), 1792-1799. https://doi.org/10.2337/dc18-2515
  9. Vloemans, A. F., Eilander, M. M. A., Rotteveel, J., Bakker-van Waarde, W. M., Houdijk, E. C. A. M., Nuboer, R., Winterdijk, P., Snoek, F. J., & De Wit, M. (2019). Youth With Type 1 Diabetes Taking Responsibility for Self-Management: The Importance of Executive Functioning in Achieving Glycemic Control: Results From the Longitudinal DINO Study. Diabetes Care, 42(2), 225-231. https://doi.org/10.2337/dc18-1143
  10. Clegg, L. E., Heerspink, H. J. L., Penland, R. C., Tang, W., Boulton, D. W., Bachina, S., Fox, R. D., Fenici, P., Thuresson, M., Mentz, R. J., Hernandez, A. F., & Holman, R. R. (2019). Reduction of Cardiovascular Risk and Improved Estimated Glomerular Filtration Rate by SGLT2 Inhibitors, Including Dapagliflozin, Is Consistent Across the Class: An Analysis of the Placebo Arm of EXSCEL. Diabetes Care, 42(2), 318-326. https://doi.org/10.2337/dc18-1871
  11. 2018
  12. Ozcan, B., Rutters, F., Snoek, F. J., Roosendaal, M., Sijbrands, E. J., Elders, P. J. M., Holleman, F., Pijl, H., Tack, C. J., Abbink, E. J., de Valk, H. W., Wolffenbuttel, B. H. R., Stehouwer, C. D. A., Schaper, N. C., Dekker, J. M., Schram, M. T., & Diabet Peart Parelsnoer Initiative (2018). High Diabetes Distress Among Ethnic Minorities Is Not Explained by Metabolic, Cardiovascular, or Lifestyle Factors: Findings From the Dutch Diabetes Pearl Cohort. Diabetes Care, 41(9), 1854-1861. https://doi.org/10.2337/dc17-2181
  13. BEAt-DKD Consortium, Heinzel, A., Kammer, M., Mayer, G., Reindl-Schwaighofer, R., Hu, K., Perco, P., Eder, S., Rosivall, L., Mark, P. B., Ju, W., Kretzler, M., Gilmour, P., Wilson, J. M., Duffin, K. L., Abdalla, M., McCarthy, M. I., Heinze, G., Heerspink, H. L., ... Oberbauer, R. (2018). Validation of Plasma Biomarker Candidates for the Prediction of eGFR Decline in Patients With Type 2 Diabetes. Diabetes Care, 41(9), 1947-1954. https://doi.org/10.2337/dc18-0532
  14. Yamamoto, J. M., Kellett, J. E., Balsells, M., Garcia-Patterson, A., Hadar, E., Sola, I., Gich, I., van der Beek, E. M., Castaneda-Gutierrez, E., Heinonen, S., Hod, M., Laitinen, K., Olsen, S. F., Poston, L., Rueda, R., Rust, P., van Lieshout, L., Schelkle, B., Murphy, H. R., & Corcoy, R. (2018). Gestational Diabetes Mellitus and Diet: A Systematic Review and Meta-analysis of Randomized Controlled Trials Examining the Impact of Modified Dietary Interventions on Maternal Glucose Control and Neonatal Birth Weight. Diabetes Care, 41(7), 1346-1361. https://doi.org/10.2337/dc18-0102
  15. Oosterom, N., Gant, C. M., Ruiterkamp, N., van Beijnum, B-J. F., Hermens, H., Bakker, S. J. L., Navis, G., Vollenbroek-Hutten, M. M. R., & Laverman, G. D. (2018). Physical Activity in Patients With Type 2 Diabetes: The Case for Objective Measurement in Routine Clinical Care. Diabetes Care, 41(4), E50-E51. https://doi.org/10.2337/dc17-2041
  16. 2017
  17. Lauri, C., Tamminga, M., Glaudemans, A. W. J. M., Juárez Orozco, L. E., Erba, P. A., Jutte, P. C., Lipsky, B. A., IJzerman, M. J., Signore, A., & Slart, R. H. J. A. (2017). Detection of Osteomyelitis in the Diabetic Foot by Imaging Techniques: A Systematic Review and Meta-analysis Comparing MRI, White Blood Cell Scintigraphy, and FDG-PET. Diabetes Care, 40(8), 1111-1120. https://doi.org/10.2337/dc17-0532
  18. Eisenga, M. F., Zelle, D. M., Sloan, J. H., Gaillard, C. A. J. M., Bakker, S. J. L., & Dullaart, R. P. F. (2017). High Serum PCSK9 Is Associated With Increased Risk of New-Onset Diabetes After Transplantation in Renal Transplant Recipients. Diabetes Care, 40(7), 894-901. https://doi.org/10.2337/dc16-2258
  19. Smits, K. P. J., Sidorenkov, G., Navis, G., Bouma, M., Meulepas, M. A., Bilo, H. J. G., & Denig, P. (2017). Prescribing Quality and Prediction of Clinical Outcomes in Patients With Type 2 Diabetes: A Prospective Cohort Study. Diabetes Care, 40(7), E83-E84. https://doi.org/10.2337/dc17-0236
  20. Bidadkosh, A., Lambooy, S. P. H., Heerspink, H. J., Pena, M. J., Henning, R. H., Buikema, H., & Deelman, L. E. (2017). Predictive Properties of Biomarkers GDF-15, NTproBNP, and hs-TnT on Morbidity and Mortality in Type 2 Diabetes Patients With Nephropathy. Diabetes Care, 40(6), 784-792. https://doi.org/10.2337/dc16-2175
  21. Mayer, G., Heerspink, H. J. L., Aschauer, C., Heinzel, A., Heinze, G., Kainz, A., Sunzenauer, J., Perco, P., de Zeeuw, D., Rossing, P., Pena, M., Oberbauer, R., & SYSKID Consortium (2017). Systems Biology-Derived Biomarkers to Predict Progression of Renal Function Decline in Type 2 Diabetes. Diabetes Care, 40(3), 391-397. https://doi.org/10.2337/dc16-2202
  22. 2016
  23. de Boer, S. A., Hovinga-de Boer, M. C., Heerspink, H. J. L., Lefrandt, J. D., van Roon, A. M., Lutgers, H. L., Glaudemans, A. W. J. M., Kamphuisen, P. W., Slart, R. H. J. A., & Mulder, D. J. (2016). Arterial Stiffness Is Positively Associated With F-18-fluorodeoxyglucose Positron Emission Tomography-Assessed Subclinical Vascular Inflammation in People With Early Type 2 Diabetes. Diabetes Care, 39(8), 1440-1447. https://doi.org/10.2337/dc16-0327
  24. 2015
  25. Lotta, L. A., Abbasi, A., Sharp, S. J., Sahlqvist, A-S., Waterworth, D., Brosnan, J. M., Scott, R. A., Langenberg, C., & Wareham, N. J. (2015). Definitions of Metabolic Health and Risk of Future Type 2 Diabetes in BMI Categories: A Systematic Review and Network Meta-analysis. Diabetes Care, 38(11), 2177-2187. https://doi.org/10.2337/dc15-1218
  26. Gutierrez-Achury, J., Romanos, J., Bakker, S. F., Magadi Gopalaiah, V. K., de Haas, E. C., Trynka, G., Ricano-Ponce, I., Steck, A., Chen, W-M., Onengut-Gumuscu, S., Simsek, S., Rewers, M., Mulder, C. J., Liu, E., Rich, S. S., Wijmenga, C., & Type 1 Diabet Genetics Consortium (2015). Contrasting the Genetic Background of Type 1 Diabetes and Celiac Disease Autoimmunity. Diabetes Care, 38, S37-S44. https://doi.org/10.2337/dcs15-2007
  27. Landman, G. W. D., Kleefstra, N., & Houweling, S. T. (2015). Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140-149. Diabetes Care, 38(8), E127-E127. https://doi.org/10.2337/dc15-0276
  28. Schrijnders, D., Houweling, S. T., & Landman, G. W. D. (2015). Should Sulfonylureas Remain an Acceptable First-Line Add-on to Metformin Therapy in Patients With Type 2 Diabetes? No, It's Time to Move On! Diabetes Care 2015;38: 170-175. Diabetes Care, 38(6), E94-E94. https://doi.org/10.2337/dc15-0293
  29. Signore, A., Capriotti, G., Chianelli, M., Bonanno, E., Galli, F., Catalano, C., Quintero, A. M., De Toma, G., Manfrini, S., Pozzilli, P., & Action LADA Grp (2015). Detection of Insulitis by Pancreatic Scintigraphy With Tc-99m-Labeled IL-2 and MRI in Patients With LADA (Action LADA 10). Diabetes Care, 38(4), 652-658. https://doi.org/10.2337/dc14-0580
  30. Neal, B., Perkovic, V., de Zeeuw, D., Mahaffey, K. W., Fulcher, G., Ways, K., Desai, M., Shaw, W., Capuano, G., Alba, M., Jiang, J., Vercruysse, F., Meininger, G., Matthews, D., & CANVAS Trial Collaborative Grp (2015). Efficacy and Safety of Canagliflozin, an Inhibitor of Sodium-Glucose Cotransporter 2, When Used in Conjunction With Insulin Therapy in Patients With Type 2 Diabetes. Diabetes Care, 38(3), 403-411. https://doi.org/10.2337/dc14-1237
  31. Campmans-Kuijpers, M. J., Baan, C. A., Lemmens, L. C., & Rutten, G. E. (2015). Change in quality management in diabetes care groups and outpatient clinics after feedback and tailored support. Diabetes Care, 38(2), 285-92. https://doi.org/10.2337/dc14-1860
  32. 2014
  33. Diamant, M., Nauck, M. A., Shaginian, R., Malone, J. K., Cleall, S., Reaney, M., de Vries, D., Hoogwerf, B. J., MacConell, L., Wolffenbuttel, B. H. R., & 4B Study Grp (2014). Glucagon-like peptide 1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes. Diabetes Care, 37(10), 2763-2773. https://doi.org/10.2337/dc14-0876
  34. Tovote, K. A., Fleer, J., Snippe, E., Peeters, A. C. T. M., Emmelkamp, P. M. G., Sanderman, R., Links, T. P., & Schroevers, M. J. (2014). Individual Mindfulness-Based Cognitive Therapy and Cognitive Behavior Therapy for Treating Depressive Symptoms in Patients With Diabetes: Results of a Randomized Controlled Trial. Diabetes Care, 37(9), 2427-2434. https://doi.org/10.2337/dc13-2918
  35. de Mol, P., de Vries, S. T., de Koning, E. J. P., Gans, R. O. B., Bilo, H. J. G., & Tack, C. J. (2014). Physical Activity at Altitude: Challenges for People With Diabetes A Review. Diabetes Care, 37(8), 2404-2413. https://doi.org/10.2337/dc13-2302
  36. Spijker, H. S., Wolffenbuttel, B. H. R., van der Bij, W., Engelse, M. A., Rabelink, T. J., & de Koning, E. J. P. (2014). Islet-after-lung transplantation in a patient with cystic fibrosis-related diabetes. Diabetes Care, 37(7), E159-E160. https://doi.org/10.2337/dc14-0639
  37. Illgner, U., van Netten, J., Droste, C., Postema, K., Meiners, T., & Wetz, H. H. (2014). Diabetic Charcot Neuroarthropathy of the Knee: Conservative Treatment Options as Alternatives to Surgery Case Reports of Three Patients. Diabetes Care, 37(6), E129-E130. https://doi.org/10.2337/dc13-3045
  38. Landman, G. W. D., Nijenhuis-Rosien, L., & Kleefstra, N. (2014). Comment on Lazaro-Martinez et al. Antibiotics versus conservative surgery for treating diabetic foot osteomyelitis: a randomized comparative trial. Diabetes care 2014;37:789-795. Diabetes Care, 37(5), [e115]. https://doi.org/10.2337/dc13-2979
  39. Illgner, U., van Netten, J., Droste, C., Meiners, T., Postema, K., & Wetz, H. H. (2014). Diabetic Charcot Neuroarthropathy of the Hand: Clinical Course, Diagnosis, and Treatment Options. Diabetes Care, 37(5), E91-E92. https://doi.org/10.2337/dc13-2903
  40. de Vries, S. T., Voorham, J., Haaijer-Ruskamp, F. M., & Denig, P. (2014). Potential Overtreatment and Undertreatment of Diabetes in Different Patient Age Groups in Primary Care After the Introduction of Performance Measures. Diabetes Care, 37(5), 1312-1320. https://doi.org/10.2337/dc13-1861
  41. Landman, G. W. D., van Dijk, P. R., Drion, I., van Hateren, K. J. J., Struck, J., Groenier, K. H., Gans, R. O. B., Bilo, H. J. G., Bakker, S. J. L., & Kleefstra, N. (2014). Midregional Fragment of Proadrenomedullin, New-Onset Albuminuria, and Cardiovascular and All-Cause Mortality in Patients With Type 2 Diabetes (ZODIAC-30). Diabetes Care, 37(3), 839-845. https://doi.org/10.2337/dc13-1852
  42. Goedendorp, M. M., Tack, C. J., Steggink, E., Bloot, L., Bazelmans, E., & Knoop, H. (2014). Chronic fatigue in type 1 diabetes. Diabetes Care, 37(1), 73-80. https://doi.org/10.2337/dc13-0515
  43. 2013
  44. Kleefstra, N., Logtenberg, S. J. J., & Bilo, H. J. G. (2013). Comment on: Bosi et al. Intensive Structured Self-Monitoring of Blood Glucose and Glycemic Control in Noninsulin-Treated Type 2 Diabetes: The PRISMA Randomized Trial. Diabetes Care 2013;36:2887-2894. Diabetes Care, 36(12), E217-E217. https://doi.org/10.2337/dc13-1394
  45. Riphagen, I. J., Boertien, W. E., Alkhalaf, A., Kleefstra, N., Gansevoort, R. T., Groenier, K. H., van Hateren, K. J. J., Struck, J., Navis, G., Bilo, H. J. G., & Bakker, S. J. L. (2013). Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-31). Diabetes Care, 36(10), 3201-3207. https://doi.org/10.2337/dc12-2165
  46. Wolffenbuttel, B. H. R., Herman, W. H., Gross, J. L., Dharmalingam, M., Jiang, H. H., & Hardin, D. S. (2013). Ethnic differences in glycemic markers in patients with type 2 diabetes. Diabetes Care, 36(10), 2931-2936. https://doi.org/10.2337/dc12-2711
  47. Jørgensen, M. E., Borch-Johnsen, K., Stolk, R., & Bjerregaard, P. (2013). Fat distribution and glucose intolerance among Greenland Inuit. Diabetes Care, 36(10), 2988-2994. https://doi.org/10.2337/dc12-2703
  48. Zelle, D. M., Corpeleijn, E., Deinum, J., Stolk, R. P., Gans, R. O. B., Navis, G., & Bakker, S. J. L. (2013). Pancreatic beta-Cell Dysfunction and Risk of New-Onset Diabetes After Kidney Transplantation. Diabetes Care, 36(7), 1926-1932. https://doi.org/10.2337/dc12-1894
  49. Sinkeler, S. J., Kwakernaak, A. J., Bakker, S. J. L., Shahinfar, S., Esmatjes, E., de Zeeuw, D., Navis, G., & Heerspink, H. J. L. (2013). Creatinine Excretion Rate and Mortality in Type 2 Diabetes and Nephropathy. Diabetes Care, 36(6), 1489-1494. https://doi.org/10.2337/dc12-1545
  50. van Hateren, K. J. J., Landman, G. W. D., Kleefstra, N., Groenier, K. H., Struck, J., Navis, G. J., Bakker, S. J. L., Houweling, S. T., van der Meer, K., & Bilo, H. J. G. (2013). The Midregional Fragment of Pro-A-Type Natriuretic Peptide, Blood Pressure, and Mortality in a Prospective Cohort Study of Patients With Type 2 Diabetes (ZODIAC-25). Diabetes Care, 36(5), 1347-1352. https://doi.org/10.2337/dc12-0428
  51. Dekker, L. H., Nicolaou, M., van der A, D. L., Busschers, W. B., Brewster, L. M., Snijder, M. B., Stronks, K., & van Valkengoed, I. G. M. (2013). Sex differences in the association between serum ferritin and fasting glucose in type 2 diabetes among South Asian Surinamese, African Surinamese, and ethnic Dutch: the population-based SUNSET study. Diabetes Care, 36(4), 965-971. https://doi.org/10.2337/dc12-1243
  52. 2012
  53. Hellemons, M. E., Mazagova, M., Gansevoort, R. T., Henning, R. H., de Zeeuw, D., Bakker, S. J. L., Lambers-Heerspink, H. J., & Deelman, L. E. (2012). Growth-Differentiation Factor 15 Predicts Worsening of Albuminuria in PatientsWith Type 2 Diabetes. Diabetes Care, 35(11), 2340-2346. https://doi.org/10.2337/dc12-0180
  54. Morton, J., Zoungas, S., Li, Q., Patel, A. A., Chalmers, J., Woodward, M., Celermajer, D. S., Beulens, J. W. J., Stolk, R. P., Glasziou, P., Ng, M. K. C., & ADVANCE Collaborative Grp (2012). Low HDL Cholesterol and the Risk of Diabetic Nephropathy and Retinopathy Results of the ADVANCE study. Diabetes Care, 35(11), 2201-2206. https://doi.org/10.2337/dc12-0306
  55. Drion, I., Kleefstra, N., Landman, G. W. D., Alkhalaf, A., Struck, J., Groenier, K. H., Bakker, S. J. L., & Bilo, H. J. G. (2012). Plasma COOH-Terminal Proendothelin-1 A marker of fatal cardiovascular events, all-cause mortality, and new-onset albuminuria in type 2 diabetes? (ZODIAC-29). Diabetes Care, 35(11), 2354-2358. https://doi.org/10.2337/dc11-2526
  56. de Mol, P., Fokkert, M. J., de Vries, S. T., de Koning, E. J. P., Dikkeschei, B. D., Gans, R. O. B., Tack, C. J., & Bilo, H. J. G. (2012). Metabolic Effects of High Altitude Trekking in Patients With Type 2 Diabetes. Diabetes Care, 35(10), 2018-2020. https://doi.org/10.2337/dc12-0204
  57. Alssema, M., Newson, R. S., Bakker, S. J. L., Stehouwer, C. D. A., Heymans, M. W., Nijpels, G., Hillege, H. L., Hofman, A., Witteman, J. C. M., Gansevoort, R. T., & Dekker, J. M. (2012). One Risk Assessment Tool for Cardiovascular Disease, Type 2 Diabetes, and Chronic Kidney Disease. Diabetes Care, 35(4), 741-748. https://doi.org/10.2337/dc11-1417
  58. Bot, M., Pouwer, F., Zuidersma, M., van Melle, J. P., & de Jonge, P. (2012). Association of Coexisting Diabetes and Depression With Mortality After Myocardial Infarction. Diabetes Care, 35(3), 503-509. https://doi.org/10.2337/dc11-1749
  59. Swelheim, H. T., Westerlaken, C., van Pinxteren-Nagler, E., & Bocca, G. (2012). Lipoatrophy in a Girl With Type 1 Diabetes: Beneficial Effects of Treatment With a Glucocorticoid Added to an Insulin Analog. Diabetes Care, 35(3), E22-E22. https://doi.org/10.2337/dc11-2135
Previous 1 2 3 Next

ID: 778209

University of Groningen staff: edit these data

print
Follow the UGfacebook twitter linkedin rss instagram youtube